Actively Recruiting
Different Treatment Strategies on Prognosis of Acute Ischemic Stroke(AISDTS)
Led by Nanjing First Hospital, Nanjing Medical University · Updated on 2026-04-09
5000
Participants Needed
1
Research Sites
265 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
AISDTS is a prospective registry study, in which clinical information, examination and imaging data of patients with acute ischemic stroke receiving different treatment strategies were collected, grouped and statistically analyzed, and corresponding clinical prediction models were constructed to explore the role of clinical biological indicators in the occurrence and development of stroke.
CONDITIONS
Official Title
Different Treatment Strategies on Prognosis of Acute Ischemic Stroke(AISDTS)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 years of age or older
- Hospital admission for ischemic stroke
- Signed informed consent
You will not qualify if you...
- Patients with incomplete clinical information
- Hospital stay less than 24 hours
- Recent trauma, severe inflammation, severe liver or kidney dysfunction, progressive malignancy, or other serious diseases
- Baseline modified Rankin Scale score greater than 2
- Informed consent not signed
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Nanjing First Hospital, Nanjing Medical University
Nanjing, Jiangsu, China, 210006
Actively Recruiting
Research Team
Q
Qiwen Deng, M.D.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
6
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here